LOAME
BDRX

Lombard Odier Asset Management (Europe)’s Biodexa Pharmaceuticals BDRX Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$110K – 274
2022
Q3 		$110K Buy
+1
New +$110K 0.01% 276